Global Pyrazinamide Market, by Patient Type (Adult and Pediatric), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 143.9 million in 2020 and is expected to exhibit a CAGR of 4.6% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Global Pyrazinamide Market - Impact of Coronavirus (COVID-19) Pandemic
The outbreak of COVID-19 has created challenges for several industries and markets worldwide. Due to rise in COVID 19 cases, society and healthcare facilities have paid more attention to the healthcare industry, which will impose both positive and negative impact across its different sub-sectors. In the short term, the pharma companies, healthcare institutions, pharmaceutical distribution and retail have negative impact of COVID-19 spread. According to the World Health Organization, in December 2019, the manifestation of coronavirus disease (COVID-19) has resulted in over 29.6 million infected individuals worldwide as of September 2020. The COVID-19 pandemic has affected the global economy in three main ways; by directly affecting production and demand, by negatively impacting the supply chain and market disruption, and through its financial impact on firms and financial markets. This negative economic impact is expected to hamper growth of various pharmaceutical markets, including the global pyrazinamide market.
Moreover, severe economic crisis and broken supply chain is a major issue faced by players operating in the Pyrazinamide Market across globe. The pandemic has negatively impacted the medical healthcare industry, in terms of services provided by the healthcare facilities. As a result, the global pyrazinamide market growth is also expected to witness a slowdown till the period of COVID-19 control.
Browse 28 Market Data Tables and 25 Figures spread through 149 Pages and in-depth TOC on Global Pyrazinamide Market, by Patient Type (Adult and Pediatric), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), - Forecast to 2027"
To know the latest trends and insights related to Global Pyrazinamide Market, click the link below:
Moreover, according to the WHO, South-East Asia (SEA) region is home to 26% of the world’s population with 44% burden of TB incidence. As per same data source, in 2019, an estimated 4.3 million people suffered from TB and it is estimated that 632,000 died because of TB disease.
Key Takeaways of the Global Pyrazinamide Market: